Karen P
I built this matrix by mapping each row to the single trial endpoint that produced the highest-quality primary evidence as of mid-2026: percent body-weight change for efficacy (Jastreboff 2023, SURMOUNT-1, STEP 1), three-point MACE for cardiovascular (SELECT), MRI-PDFF for hepatic fat (retatrutide Phase 2 sub-analyses, [unverified primary source]), and treatment-emergent adverse event rates for GI burden
Attribution language throughout this article identifies statements as brand claims
& Loke, Y
Considering this evidence, increasing neurogenesis in the brain through the GLP-1 pathway may provide a novel approach for improving depressive-like behavior in patients with depression
EXCELLENT Based on 65 reviews Margarita Del ValleFebruary 27, 2026Trustindex verifies that the original source of the review is Google.Excelente trato, muy profesional y competente.Rachel Rabelo del ValleFebruary 27, 2026Trustindex verifies that the original source of the review is Google.Tuve un trato excelente, y la mejor de las atencionesMercy GonzalezFebruary 7, 2026Trustindex verifies that the original source of the review is Google.I am very happy with the care I receive at this medical clinic
